Variant Bio

Variant Bio is a biotechnology company developing life-saving therapies by studying the genes of people with exceptional health-related traits. Working with partner communities around the world under an ethical, benefit-sharing approach, the company pairs large-scale genomic discovery with data science to turn genetic diversity into novel drug targets across metabolic, cardiovascular and other disease areas. Surfaced as a portfolio company of General Catalyst, Lux Capital and SoftBank Vision Fund and profiled in the API Evangelist network; Variant Bio publishes no public developer/API surface at this time.

Variant Bio is profiled on the APIs.io network. Tagged areas include Company, Genomics, Therapeutics, Drug Discovery, and Biotechnology.

Variant Bio’s developer surface includes engineering blog and 3 more developer resources.

9.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyGenomicsTherapeuticsDrug DiscoveryBiotechnologyPrecision Medicine

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 9.3/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/variant-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Variant Bio Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Commercial 1

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: variant-bio
name: Variant Bio
description: Variant Bio is a biotechnology company developing life-saving therapies by studying the genes of people with
  exceptional health-related traits. Working with partner communities around the world under an ethical, benefit-sharing approach,
  the company pairs large-scale genomic discovery with data science to turn genetic diversity into novel drug targets across
  metabolic, cardiovascular and other disease areas. Surfaced as a portfolio company of General Catalyst, Lux Capital and
  SoftBank Vision Fund and profiled in the API Evangelist network; Variant Bio publishes no public developer/API surface at
  this time.
url: https://raw.githubusercontent.com/api-evangelist/variant-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
- lux-capital
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://variant-bio.transforms.svdcdn.com/production/default/social-share.jpg
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Genomics
- Therapeutics
- Drug Discovery
- Biotechnology
- Precision Medicine
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/variant-bio-domain-security.yml
- type: Website
  url: https://www.variantbio.com
- type: Blog
  url: https://medium.com/variantbio/
- type: PrivacyPolicy
  url: https://www.variantbio.com/privacy
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1